Astaxanthin as a potential therapeutic agent in polycystic ovary syndrome: a review of its antioxidant, anti-inflammatory, and metabolic mechanisms - Top-Institutions - MDSpire

Astaxanthin as a potential therapeutic agent in polycystic ovary syndrome: a review of its antioxidant, anti-inflammatory, and metabolic mechanisms

  • By

  • Jialai Wang

  • Ying Yang

  • Ziwei Wang

  • Chengdong Liu

  • Yanhua Han

  • Xiaoke Wu

  • Hui Chang

  • July 13, 2026

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    Tehran University of Medical Sciences
    Tehran University of Medical Sciences

    Tehran, Iran

    Key Differentiators

    • Endocrinology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Metabolism

  • #3

    UK Biobank
    UK Biobank

    UK, N/A

    Key Differentiators

    • Epidemiology
    • Endocrinology

Original Source(s)

Astaxanthin as a potential therapeutic agent in polycystic ovary syndrome: a review of its antioxidant, anti-inflammatory, and metabolic mechanisms

  • by Jialai Wang, Ying Yang, Ziwei Wang, Chengdong Liu, Yanhua Han, Xiaoke Wu, Hui Chang

  • July 13, 2026

Related Content

The role of metabolic reprogramming in oocyte development: research progress and prospects

High serum FSH levels on day 7 of stimulation are negatively associated with oocyte retrieval in GnRH antagonist protocols: real-world evidence from 9,969 IVF cycles in China

PCOS’s new name is PMOS, a small letter change that required a big scientific process